These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 6769160)

  • 1. [Post-transfusion hepatitis].
    Frey-Wettstein M
    Schweiz Med Wochenschr Suppl; 1980; (10):1-40. PubMed ID: 6769160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory tests in Japanese Red Cross Blood Centers to prevent transfusion-transmitted diseases].
    Watanabe J
    Rinsho Byori; 1991 Mar; Suppl 88():60-9. PubMed ID: 1906951
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of HB Ag and HB Ab in the Canadian blood-donor population.
    Moore BP
    Haematologia (Budap); 1974; 8(1-4):409-13. PubMed ID: 4461428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does a "hepatitis C" besides hepatitis B play an important part in blood transfusion disorders?].
    Frösner G
    Internist (Berl); 1976 May; 17(5):256-7. PubMed ID: 58848
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum hepatitis in donors and recipients].
    Khazanov AI; Stulov AP; Korolev SS; Ivlev AS; Verteletskiĭ VV
    Voen Med Zh; 1978 Dec; (12):41-3. PubMed ID: 734959
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN; Perkins HA
    N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Posttransfusion hepatitis in Kuala Lumpur.
    Kamath S; Lopez CG
    Med J Aust; 1973 Nov; 2(18):867-8. PubMed ID: 4782397
    [No Abstract]   [Full Text] [Related]  

  • 10. [Australia antigen, a review. 3. Pathways of transmission, hepatitis after blood transfusion, in dialysis units, methods for the demonstration of hepatitis B (surface) antigens and antibodies].
    Ohlen J; Richter J
    Fortschr Med; 1976 Jan; 94(1):23-7, 30-2. PubMed ID: 783026
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis.
    Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL
    N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc.
    Hopkins R; Kane E; Robertson AE; Haase G
    Med Lab Sci; 1982 Jan; 39(1):61-2. PubMed ID: 7098783
    [No Abstract]   [Full Text] [Related]  

  • 15. [Technics of detection of Australia antigen and corresponding antibodies in blood transfusion centers].
    Vranckx R
    Arch Belg Med Soc; 1973 Apr; 31(4):222-54. PubMed ID: 4202183
    [No Abstract]   [Full Text] [Related]  

  • 16. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 18. Does blood with antibodies against hepatitis B carry an increased risk to transmit hepatitis.
    Vox Sang; 1975; 28(6):460-7. PubMed ID: 1146274
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.